---
title: "BTTX.US (BTTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BTTX.US/news.md"
symbol: "BTTX.US"
name: "BTTX.US"
parent: "https://longbridge.com/en/quote/BTTX.US.md"
datetime: "2026-03-08T08:16:03.389Z"
locales:
  - [en](https://longbridge.com/en/quote/BTTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BTTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BTTX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BTTX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BTTX.US/news.md)


# BTTX.US (BTTX.US) — Related News

### [Why Are Shares Of Xeris Biopharma Falling Friday?](https://longbridge.com/en/news/277234588.md)
*2026-02-27T17:29:00.000Z*
> Xeris Biopharma Holdings shares fell 10.83% to $6.01 after announcing a patent infringement lawsuit against Torrent Phar

### [Xeris Biopharma Subsidiaries File Recorlev® Patent Infringement Lawsuit | XERS Stock News](https://longbridge.com/en/news/277111238.md)
*2026-02-26T14:55:00.000Z*
> Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) announced that its subsidiaries have filed a patent infringement lawsuit a

### [Egetis Therapeutics FY Revenue At SEK 62.3 Million, Below IBES Estimate](https://longbridge.com/en/news/276991916.md)
*2026-02-26T06:23:44.000Z*
> Feb 26 (Reuters) - Egetis Therapeutics AB (publ) (EGTX.ST) :FY REVENUE SEK 62.3 MILLION VERSUS. IBES ESTIMATE SEK 67.2 M

### [Expert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts](https://longbridge.com/en/news/276492463.md)
*2026-02-20T22:01:18.000Z*
> In the past three months, four analysts have evaluated Beam Therapeutics (NASDAQ:BEAM), showing a range of sentiments fr

### [Bicycle Therapeutics (BCYC) Projected to Post Quarterly Earnings on Tuesday](https://longbridge.com/en/news/276110215.md)
*2026-02-17T09:53:24.000Z*
> Bicycle Therapeutics (NASDAQ:BCYC) is set to release its Q4 2025 earnings on February 24, with analysts expecting a loss

### [Strong clinical data for Breye lead asset danegaptide](https://longbridge.com/en/news/275297165.md)
*2026-02-09T09:47:27.000Z*
> Breye Therapeutics has announced promising early clinical results for its oral therapy danegaptide, presented at the Ang

### [Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.;  Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market](https://longbridge.com/en/news/204186587.md)
*2024-05-15T20:50:00.000Z*
> The Nasdaq Stock Market will delist the securities of Better Therapeutics, Inc., Tritium DCFC Limited, Arcimoto, Inc., N

### [12 Health Care Stocks Moving In Friday's After-Market Session](https://longbridge.com/en/news/200003625.md)
*2024-03-15T21:33:52.000Z*
> Gainers in the after-market session include Cue Health, Aclarion, BioSig Technologies, OptiNose, SCWorx, and Avenue Ther

### [Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://longbridge.com/en/news/109968652.md)
*2024-03-14T17:46:49.000Z*
> Limbach Holdings shares fell 15% after reporting lower-than-expected fourth-quarter results and issuing below-estimate r

### [BUZZ-Better Therapeutics tumbles 81% on plans to wind down operations](https://longbridge.com/en/news/109963077.md)
*2024-03-14T15:23:22.000Z*
> Better Therapeutics, a digital therapeutics company, experienced an 81% drop in its stock and plans to wind down operati